Skip to main content

Table 1 Patients characteristics

From: The role of cell-free hemoglobin and haptoglobin in acute kidney injury in critically ill adults with ARDS and therapy with VV ECMO

Characteristic

Low CFH

[< 5 mg/dl]

(N = 79)

Moderate CFH

[5–14 mg/dl]

(N = 136)

High CFH

[≥ 15 mg/dl]

(N = 58)

P value*

CFH concentration

3.00 [2.00, 3.60]

8.00 [6.00, 10.25]

23.00 [17.25, 42.25]

< 0.001

Age (years)

48.00 [37.50, 64.00]

53.00 [40.00, 64.00]

46.00 [28.50, 55.75]

0.030

Male sex, n (%)

58 (73.4)

87 (64.0)

38 (65.5)

0.351

Body mass index (kg/cm)

24.84 [21.60, 27.78]

26.12 [22.17, 29.93]

24.49 [21.57, 30.96]

0.454

Charlson comorbidity index

2.00 [0.50, 5.00]

3.00 [1.00, 4.00]

2.00 [0.00, 4.00]

0.359

Chronic kidney disease, n (%)

6 (7.6)

13 (9.6)

6 (10.3)

0.837

Immunocompromised, n (%)

19 (24.1)

38 (27.9)

15 (25.9)

0.819

SOFA at ARDS onset

11.00 [8.00, 14.00]

12.00 [9.75, 15.00]

14.50 [11.25, 16.75]

< 0.001

SAPS II at ARDS onset

49.00 [35.50, 63.50]

58.00 [42.00, 70.25]

59.50 [47.00, 77.00]

0.005

Chronic lung disease, n (%)

32 (40.5)

51 (37.5)

16 (27.6)

0.273

Pulmonary origin, n (%)

74 (93.7)

120 (88.2)

44 (75.9)

0.008

ARDS severity, n (%)

    

 Severe

76 (96.2)

130 (95.6)

56 (96.6)

0.945

ARDS etiology, n (%)

   

0.387

 Pneumonia

54 (70.1)

92 (70.2)

32 (55.2)

 

 Aspiration pneumonitis

5 (6.5)

13 (9.9)

8 (13.8)

 

 Trauma and burns

1 (1.3)

5 (3.8)

2 (3.4)

 

 Other acute respiratory diagnoses

6 (7.8)

11 (8.4)

8 (13.8)

 

 Nonrespiratory and chronic respiratory diagnoses

11 (14.3)

10 (7.6)

8 (13.8)

 

ECMO initiation, n (%)

   

0.705

Mobile ECMO retrieval team

20 (25.3)

35 (25.7)

18 (31.0)

 

After admission

59 (74.7)

101 (74.3)

40 (69.0)

 

ECMO initiation (ICU day)

0.00 [0.00, 0.00]

0.00 [0.00, 0.00]

0.00 [0.00, 0.00]

0.564

Ventilation parameters at ECMO initiation

    

 Mechanical ventilation (days)

3.00 [1.00, 7.50]

2.00 [1.00, 5.50]

1.50 [1.00, 4.00]

0.312

 PaO2:FiO2 (mmHg)

76.00 [58.66, 89.30]

68.49 [56.12, 90.00]

60.90 [50.76, 85.50]

0.267

 PaO2 (mmHg)

72.50 [56.22, 85.72]

66.40 [52.10, 86.55]

57.30 [50.50, 85.50]

0.440

 PaCO2 (mmHg)

69.00 [56.60, 88.05]

62.45 [50.35, 78.40]

71.50 [57.55, 82.40]

0.153

 pH

7.25 [7.18, 7.35]

7.25 [7.17, 7.36]

7.20 [7.11, 7.27]

0.095

 PIP (cmH2O)

36.20 [31.63, 40.25]

36.86 [32.67, 42.00]

40.50 [36.00, 47.00]

0.001

 Pplateau (cmH2O)

33.19 [29.00, 36.02]

33.44 [30.00, 38.00]

38.00 [31.00, 41.00]

0.011

 PEEP (cm H2O)

18.20 [15.30, 20.00]

18.20 [16.00, 20.40]

20.40 [17.00, 22.00]

0.013

 Driving pressure (cmH2O)

15.60 [11.00, 17.07]

14.00 [11.00, 19.40]

17.00 [12.85, 20.60]

0.179

 Tidal volume (ml/kg PBW)

5.32 [3.55, 7.80]

5.44 [3.88, 7.41]

5.27 [3.86, 6.96]

0.836

 Respiratory rate (breaths/min)

25.00 [20.00, 34.34]

24.25 [20.00, 30.05]

25.00 [19.74, 31.79]

0.742

 Compliance (ml/cm H2O)

24.61 [15.25, 32.00]

23.80 [13.06, 33.78]

17.09 [9.73, 22.74]

< 0.001

Further rescue therapy, n (%)

    

 Inhaled nitric oxide

54 (68.4)

95 (69.9)

41 (70.7)

0.954

 Prone positioning

60 (75.9)

100 (73.5)

44 (75.9)

0.902

Organ failure at ECMO initiation, n (%)

    

 Coagulation

13 (16.5)

47 (34.6)

31 (53.4)

< 0.001

 Liver

7 (8.9)

18 (13.2)

12 (20.7)

0.134

 Cardiovascular

76 (100.0)

123 (100.0)

55 (100.0)

NA

 CNS

42 (53.2)

71 (52.2)

27 (46.6)

0.712

 Renal (KDIGO 3)

29 (36.7)

81 (59.6)

44 (75.9)

< 0.001

Septic shock, n (%)

34 (43.0)

79 (58.1)

39 (67.2)

0.014

RRT, n (%)

28 (35.4)

77 (56.6)

44 (75.9)

< 0.001

28-day mortality, n (%)

18 (22.8)

53 (39.0)

32 (55.2)

0.001

  1. Data are expressed as median (25%-75% quartiles) or frequencies (%), as appropriate
  2. CFH, cell-free hemoglobin; SOFA, Sequential Organ Failure Assessment; SAPS, Simplified Acute Physiology Score; ECMO, extracorporeal membrane oxygenation; PIP, peak inspiratory pressure; Pplateau, plateau pressure; PEEP, positive end-expiratory pressure; RRT, renal replacement therapy
  3. *P value was calculated comparing low, moderate, and high CFH groups using the Kruskal–Wallis test and the Fisher’s exact test, as appropriate